Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

334
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
334
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157
Hepatic Portal System01:21

Hepatic Portal System

5.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

193
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
193
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

1.9K
The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis use.

Infectious diseases now·2026
Same author

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Pregnancy and iron: Bridging metabolic demands and supplementation needs.

Clinical nutrition ESPEN·2026
Same author

The Value of Reversible Carbon Storage in a Zero-Emissions World.

Environmental science & technology·2026
Same author

Building an Ontology-Based Cohort of Liver Cancer Imaging Data for AI Development on the European Federated Platform EUCAIM.

Studies in health technology and informatics·2026
Same author

Combining MRI criterion and pathology-based microvascular invasion improves prognostic stratification in early HCC.

JHEP reports : innovation in hepatology·2026

Related Experiment Video

Updated: Jan 7, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.3K

[When should vascular liver disease be considered?]

Jérôme Dumortier1, Maxime Ronot2, Aurélie Beaufrère3

  • 1Service d'hépato-gastroentérologie, hôpital Édouard-Herriot, Hospices civils de Lyon, Lyon, France.

La Revue Du Praticien
|December 30, 2025
PubMed
Summary

Vascular liver diseases (VLD) are rare and challenging to diagnose, often leading to delayed treatment. Early, multidisciplinary diagnosis is crucial for effective management and improved patient outcomes.

Keywords:
angiopathyhepatic disease

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.3K
Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice
11:10

Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice

Published on: September 13, 2016

8.6K

Related Experiment Videos

Last Updated: Jan 7, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.3K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.3K
Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice
11:10

Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice

Published on: September 13, 2016

8.6K

Area of Science:

  • Hepatology
  • Vascular Medicine
  • Diagnostic Radiology

Background:

  • Vascular liver diseases (VLD) are uncommon and frequently diagnosed late, delaying essential treatment.
  • Diagnosis often requires a multidisciplinary approach involving clinicians, radiologists, and pathologists.
  • Unexplained abnormal liver tests or portal hypertension without cirrhosis are key indicators of porto-sinusoidal vascular disease.

Purpose of the Study:

  • To highlight the diagnostic challenges and multidisciplinary nature of vascular liver diseases.
  • To emphasize the importance of early detection for timely intervention.
  • To discuss clinical presentations that should raise suspicion for VLD.

Main Methods:

  • Review of diagnostic pathways for VLD.
  • Emphasis on multidisciplinary team collaboration (clinician, radiologist, pathologist).
  • Identification of key clinical signs and patient contexts suggestive of VLD.

Main Results:

  • VLD diagnosis is often delayed due to non-specific symptoms and rarity.
  • Acute splanchnic thrombosis presents with abdominal pain; Budd-Chiari syndrome mimics other liver diseases.
  • Multidisciplinary dialogue is essential for identifying VLD, distinguishing it from common liver conditions.

Conclusions:

  • Early diagnosis of VLD is critical for optimal patient management.
  • Suspicion of VLD should arise in specific clinical scenarios, prompting further investigation.
  • Timely diagnosis facilitates treatments like anticoagulation and management of portal hypertension.